JP2021505546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505546A5 JP2021505546A5 JP2020529346A JP2020529346A JP2021505546A5 JP 2021505546 A5 JP2021505546 A5 JP 2021505546A5 JP 2020529346 A JP2020529346 A JP 2020529346A JP 2020529346 A JP2020529346 A JP 2020529346A JP 2021505546 A5 JP2021505546 A5 JP 2021505546A5
- Authority
- JP
- Japan
- Prior art keywords
- nicotine
- orally disintegrating
- tablet
- tablet according
- disintegrating nicotine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 118
- 229960002715 nicotine Drugs 0.000 claims description 107
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 107
- 239000003826 tablet Substances 0.000 claims description 96
- 239000000843 powder Substances 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 210000003296 saliva Anatomy 0.000 claims description 8
- 206010057852 Nicotine dependence Diseases 0.000 claims description 7
- 239000007884 disintegrant Substances 0.000 claims description 6
- 229920005862 polyol Polymers 0.000 claims description 5
- 150000003077 polyols Chemical class 0.000 claims description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000003456 ion exchange resin Substances 0.000 claims description 3
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 229920006318 anionic polymer Polymers 0.000 claims description 2
- 229960004874 choline bitartrate Drugs 0.000 claims description 2
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 239000006190 sub-lingual tablet Substances 0.000 claims description 2
- 229940098466 sublingual tablet Drugs 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 239000000832 lactitol Substances 0.000 claims 1
- 235000010448 lactitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims 1
- 229960003451 lactitol Drugs 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- 229960001855 mannitol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 235000010356 sorbitol Nutrition 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- SKZDZXPBBYUFBY-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCCC1C1=CC=CN=C1 SKZDZXPBBYUFBY-WLHGVMLRSA-N 0.000 description 1
- QLDPCHZQQIASHX-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.CN1CCCC1C1=CC=CN=C1 QLDPCHZQQIASHX-UHFFFAOYSA-N 0.000 description 1
- AIBWPBUAKCMKNS-UHFFFAOYSA-N 2-carboxyphenolate;3-(1-methylpyrrolidin-2-yl)pyridin-1-ium Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCCC1C1=CC=CN=C1 AIBWPBUAKCMKNS-UHFFFAOYSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- VWTHFJXLFGINSW-PPHPATTJSA-N 2-hydroxypropanoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CC(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 VWTHFJXLFGINSW-PPHPATTJSA-N 0.000 description 1
- WDXYLGOIULBYAB-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine perchloric acid Chemical compound Cl(=O)(=O)(=O)O.N1=CC=CC(=C1)C1N(C)CCC1 WDXYLGOIULBYAB-UHFFFAOYSA-N 0.000 description 1
- MMOPGICOOYBFJU-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.CN1CCCC1C1=CC=CN=C1 MMOPGICOOYBFJU-UHFFFAOYSA-N 0.000 description 1
- FFYVQVZXWDGRAY-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrate Chemical compound O.CN1CCCC1C1=CC=CN=C1 FFYVQVZXWDGRAY-UHFFFAOYSA-N 0.000 description 1
- HDJBTCAJIMNXEW-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrochloride Chemical compound Cl.CN1CCCC1C1=CC=CN=C1 HDJBTCAJIMNXEW-UHFFFAOYSA-N 0.000 description 1
- BXZYRJUYZVFANZ-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;zinc;hydrate Chemical compound O.[Zn].CN1CCCC1C1=CC=CN=C1 BXZYRJUYZVFANZ-UHFFFAOYSA-N 0.000 description 1
- MQWJVKLIBZWVEL-XRIOVQLTSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;dihydrochloride Chemical compound Cl.Cl.CN1CCC[C@H]1C1=CC=CN=C1 MQWJVKLIBZWVEL-XRIOVQLTSA-N 0.000 description 1
- HDJBTCAJIMNXEW-PPHPATTJSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;hydrochloride Chemical compound Cl.CN1CCC[C@H]1C1=CC=CN=C1 HDJBTCAJIMNXEW-PPHPATTJSA-N 0.000 description 1
- SXIBJSDOZKYORQ-UHFFFAOYSA-N 4-methylbenzenesulfonic acid 3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound S(=O)(=O)(O)C1=CC=C(C)C=C1.N1=CC=CC(=C1)C1N(C)CCC1 SXIBJSDOZKYORQ-UHFFFAOYSA-N 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 description 1
- YHBIGBYIUMCLJS-UHFFFAOYSA-N 5-fluoro-1,3-benzothiazol-2-amine Chemical compound FC1=CC=C2SC(N)=NC2=C1 YHBIGBYIUMCLJS-UHFFFAOYSA-N 0.000 description 1
- GJMKJBHRQDGHMT-UHFFFAOYSA-N C(C=CC=CC)(=O)O.N1=CC=CC(=C1)C1N(C)CCC1 Chemical compound C(C=CC=CC)(=O)O.N1=CC=CC(=C1)C1N(C)CCC1 GJMKJBHRQDGHMT-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- MHQJUHSHQGQVTM-HNENSFHCSA-N Octadecyl fumarate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)\C=C/C(O)=O MHQJUHSHQGQVTM-HNENSFHCSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- VAUQRLHPXWYZRZ-PPHPATTJSA-N benzoic acid 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)c1ccccc1.CN1CCC[C@H]1c1cccnc1 VAUQRLHPXWYZRZ-PPHPATTJSA-N 0.000 description 1
- JDIZODRSTZHAFD-UHFFFAOYSA-N butanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)CCC(O)=O.CN1CCCC1C1=CC=CN=C1 JDIZODRSTZHAFD-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ZDBSZLXHLZRTGL-UHFFFAOYSA-N dodecanoic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.CCCCCCCCCCCC(O)=O ZDBSZLXHLZRTGL-UHFFFAOYSA-N 0.000 description 1
- 229940058352 levulinate Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940071138 stearyl fumarate Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- FGAFEHZTRRYNDF-UHFFFAOYSA-L zinc;3-(1-methylpyrrolidin-2-yl)pyridine;dichloride Chemical compound [Cl-].[Cl-].[Zn+2].CN1CCCC1C1=CC=CN=C1 FGAFEHZTRRYNDF-UHFFFAOYSA-L 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201770925 | 2017-12-08 | ||
| DKPA201770925 | 2017-12-08 | ||
| PCT/DK2018/050335 WO2019110072A1 (en) | 2017-12-08 | 2018-12-07 | Nicotine tablet |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505546A JP2021505546A (ja) | 2021-02-18 |
| JP2021505546A5 true JP2021505546A5 (enExample) | 2022-01-04 |
| JP7278281B2 JP7278281B2 (ja) | 2023-05-19 |
Family
ID=64744343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529346A Active JP7278281B2 (ja) | 2017-12-08 | 2018-12-07 | ニコチン錠 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11738016B2 (enExample) |
| EP (2) | EP3906916A1 (enExample) |
| JP (1) | JP7278281B2 (enExample) |
| CN (1) | CN111447921B (enExample) |
| AU (1) | AU2018378648B2 (enExample) |
| CA (1) | CA3085062C (enExample) |
| DK (1) | DK3720418T3 (enExample) |
| ES (1) | ES2890975T3 (enExample) |
| PL (1) | PL3720418T3 (enExample) |
| WO (1) | WO2019110072A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019110075A1 (en) | 2017-12-08 | 2019-06-13 | Fertin Pharma A/S | High nicotine concentration |
| PL3720418T3 (pl) | 2017-12-08 | 2021-12-20 | Fertin Pharma A/S | Tabletka nikotynowa |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| MX2022015714A (es) | 2020-06-08 | 2023-01-24 | Nicoventures Trading Ltd | Composicion oral efervescente que comprende un ingrediente activo. |
| US11382861B1 (en) * | 2020-12-17 | 2022-07-12 | Nirajkumar Karneshbhai Patel | Nicotine pouch |
| EP4358748A1 (en) | 2021-06-25 | 2024-05-01 | Nicoventures Trading Limited | Oral products and method of manufacture |
| EP4376642A1 (en) | 2021-07-30 | 2024-06-05 | Nicoventures Trading Limited | Aerosol generating substrate comprising microcrystalline cellulose |
| CN113827575A (zh) * | 2021-11-02 | 2021-12-24 | 上海普康药业有限公司 | 一种利伐沙班片剂及其制备方法 |
| CN115969898A (zh) * | 2023-02-09 | 2023-04-18 | 东莞市吉纯生物技术有限公司 | 一种防治口腔溃疡的口含烟含片及其制备方法 |
| WO2025056129A1 (en) | 2023-09-12 | 2025-03-20 | Fertin Pharma A/S | Orally disintegrating nicotine tablet for use under lip |
| EP4543417A1 (en) | 2023-09-12 | 2025-04-30 | Fertin Pharma A/S | Orally disintegrating nicotine tablet for use under lip |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866046A (en) | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
| GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
| US5549906A (en) | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
| US5810018A (en) * | 1994-12-29 | 1998-09-22 | Monte; Woodrow C. | Method, composition and apparatus for reducing the incidence of cigarette smoking |
| EP1128817A1 (en) | 1998-10-27 | 2001-09-05 | Biovail Technologies Ltd | Microparticles containing peg and/or peg glyceryl esters |
| US6583160B2 (en) * | 1999-04-14 | 2003-06-24 | Steve Smith | Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| US6248760B1 (en) | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
| US20010016593A1 (en) | 1999-04-14 | 2001-08-23 | Wilhelmsen Paul C. | Element giving rapid release of nicotine for transmucosal administration |
| US6544552B2 (en) | 2001-01-11 | 2003-04-08 | Particle And Coating Technologies, Inc. | Method of producing porous tablets with improved dissolution properties |
| KR20030094272A (ko) * | 2001-03-06 | 2003-12-11 | 교와 핫꼬 고교 가부시끼가이샤 | 구강내 급속 붕괴성 정제 |
| NZ530439A (en) | 2001-04-20 | 2004-11-26 | Lavipharm Lab Inc | Intraoral delivery of nicotine for smoking cessation |
| US20060057207A1 (en) | 2001-11-30 | 2006-03-16 | Pfizer Inc | Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| SE0104388D0 (sv) | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| WO2004075877A1 (en) * | 2003-02-24 | 2004-09-10 | Pharmaceutical Productions, Inc. | Transmucosal drug delivery system |
| US20150080442A1 (en) | 2003-02-24 | 2015-03-19 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
| MXPA06000852A (es) | 2003-07-24 | 2006-03-30 | Smithkline Beecham Corp | Peliculas que se disuelven oralmente. |
| US7387788B1 (en) * | 2003-10-10 | 2008-06-17 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
| CA2548822C (en) * | 2003-12-08 | 2015-08-11 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
| US20070196474A1 (en) | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly disintegrating low friability tablets comprising calcium carbonate |
| ES2403167T3 (es) | 2005-12-21 | 2013-05-14 | Basf Se | Polivinilpirrolidona entrelazada finamente dividida como agente desintegrador de tabletas |
| US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US20070269386A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| KR20090055606A (ko) | 2006-09-27 | 2009-06-02 | 니코노범 에이비 | 지향성 용도 |
| EP2101744A2 (en) * | 2006-12-01 | 2009-09-23 | Cima Labs Inc. | Oral transmucosal nicotine dosage form |
| US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
| US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
| WO2009007771A1 (en) * | 2007-07-06 | 2009-01-15 | Gumlink A/S | High volume compressed chewing gum tablet |
| AR071420A1 (es) * | 2008-05-01 | 2010-06-16 | Smithkline Beecham Corp | Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla |
| SI2177213T1 (sl) | 2008-09-17 | 2013-03-29 | Siegfried Ltd. | Nikotin vsebujoč granulat |
| CN102186461A (zh) | 2008-10-14 | 2011-09-14 | 麦克内尔股份公司 | 多部分口腔内剂型及其用途 |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| EP2654735B1 (en) | 2010-12-22 | 2016-04-13 | Basf Se | Rapidly disintegrating, solid coated dosage form |
| SE535587C2 (sv) | 2011-03-29 | 2012-10-02 | Chill Of Sweden Ab | Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse |
| TW201318650A (zh) | 2011-11-02 | 2013-05-16 | Hua Yu Wuxi Pharmaceutical Co Ltd | 口崩片組成物 |
| EP2793849A1 (en) * | 2011-12-22 | 2014-10-29 | Fertin Pharma A/S | Method of releasing nicotine from chewing gum |
| US20130177646A1 (en) * | 2012-01-05 | 2013-07-11 | Mcneil Ab | Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
| US11779045B2 (en) * | 2013-10-03 | 2023-10-10 | Altria Client Services Llc | Dissolvable-chewable exhausted-tobacco tablet |
| WO2016004952A1 (en) | 2014-07-08 | 2016-01-14 | Fertin Pharma A/S | Oral delivery system comprising two compartments |
| US20170172995A1 (en) | 2015-09-08 | 2017-06-22 | Venkateswara Rao Repaka | Pharmaceutical compositions of Nicotine and process for preparation thereof |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| AU2016381372B2 (en) | 2015-12-30 | 2021-07-22 | Next Generation Labs, LLC | Nicotine replacement therapy products comprising synthetic nicotine |
| PL3720418T3 (pl) | 2017-12-08 | 2021-12-20 | Fertin Pharma A/S | Tabletka nikotynowa |
| WO2019110075A1 (en) | 2017-12-08 | 2019-06-13 | Fertin Pharma A/S | High nicotine concentration |
| EP3720498A1 (en) | 2017-12-08 | 2020-10-14 | Fertin Pharma A/S | High nicotine absorption |
| US20190174812A1 (en) | 2017-12-08 | 2019-06-13 | Fertin Pharma A/S | Solid oral nicotine formulation |
| US20200397691A1 (en) | 2017-12-08 | 2020-12-24 | Fertin Pharma A/S | Nicotine mouth spray |
-
2018
- 2018-12-07 PL PL18821992T patent/PL3720418T3/pl unknown
- 2018-12-07 CN CN201880078877.9A patent/CN111447921B/zh active Active
- 2018-12-07 ES ES18821992T patent/ES2890975T3/es active Active
- 2018-12-07 EP EP21182000.6A patent/EP3906916A1/en active Pending
- 2018-12-07 DK DK18821992.7T patent/DK3720418T3/da active
- 2018-12-07 WO PCT/DK2018/050335 patent/WO2019110072A1/en not_active Ceased
- 2018-12-07 JP JP2020529346A patent/JP7278281B2/ja active Active
- 2018-12-07 CA CA3085062A patent/CA3085062C/en active Active
- 2018-12-07 EP EP18821992.7A patent/EP3720418B1/en active Active
- 2018-12-07 AU AU2018378648A patent/AU2018378648B2/en active Active
- 2018-12-07 US US16/213,641 patent/US11738016B2/en active Active
-
2023
- 2023-07-07 US US18/348,891 patent/US12005058B2/en active Active
-
2024
- 2024-04-29 US US18/649,759 patent/US12433881B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505546A5 (enExample) | ||
| JP2021505617A5 (enExample) | ||
| JP5497435B2 (ja) | 多層口腔内崩壊錠剤 | |
| JP4989733B2 (ja) | 口腔内崩壊錠 | |
| CA2834327C (en) | New abuse-resistant pharmaceutical composition for the treatment of opioid dependence | |
| JP5421775B2 (ja) | オキシコドンを含む顆粒及び口腔内崩壊錠剤 | |
| EP3549585B1 (en) | Orally disintegrating tablet of edoxaban tosylate hydrate | |
| EA021695B1 (ru) | Быстрорастворимая оральная пленочная лекарственная форма, содержащая ребаудиозид а в качестве усилителя послевкусия и первичный подсластитель в качестве агента, маскирующего вкус | |
| ME02081B (me) | Tanke pločice buprenorfina za terapiju zamjene droge | |
| WO2006103418A1 (en) | New pharmaceutical compositions useful in the treatment of pain | |
| WO2007086457A1 (ja) | 乾式直打速崩壊性錠剤 | |
| TWI556823B (zh) | 含阿卡波糖之口崩解錠 | |
| JP2018118966A (ja) | ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 | |
| JP2011246428A (ja) | 口腔内崩壊型医薬品及びその製造方法 | |
| JP6838632B2 (ja) | 固形製剤 | |
| KR20210118164A (ko) | 필름 코팅 조성물 및 고형 제제 | |
| JP3637968B1 (ja) | 胃内崩壊性錠剤 | |
| JP2009179603A (ja) | 口腔内速崩壊性錠剤及びその製造方法 | |
| Gupta et al. | True MDTS: Mouth disintegrating tablets or mouth dissolving tablets, a comparative study | |
| JP2017052755A (ja) | 固形製剤 | |
| RU2022129278A (ru) | Твердый пероральный никотиновый состав | |
| HK40009938A (en) | Orally disintegrating tablet of edoxaban tosylate hydrate | |
| WO2002092058A1 (fr) | Preparation solide se desintegrant rapidement | |
| BR102014003686A2 (pt) | composição farmacêutica oral estável | |
| BR102013032395A2 (pt) | Composição farmacêutica oral estável |